Windtree Therapeutics (WINT) announced the appointment of Leanne Kelly to its board of directors. Kelly has served as GRI Bio’s Chief Financial Officer since April 2023.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WINT:
- Windtree lauches new corporate strategy to become revenue generating biotech
- Windtree Therapeutics announces presentation highlighting istaroxime
- Windtree Therapeutics announces new istaroxime patent filing
- Windtree Therapeutics announces partnership with New Growth Advisors
- Windtree Therapeutics Reports Q3 2024 Financial Results